-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 Thematic Report Overview Web3 is an ideology that refers to the next model of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance. This will lead the internet’s transition from an information-centric model to a user-centric model. Furthermore, Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. However, it is still an emerging model and has a long way...
-
Product Insights
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Medical Imaging Information Systems Pipeline Market Report Overview Medical imaging information systems are used in hospitals and diagnostic imaging centers to store, retrieve, modify, and forward images and information to hospital departments or imaging centers over a network. The Medical Imaging Information Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Company Profile
Alpine Immune Sciences Inc – Company Profile
Alpine Immune Sciences Inc (Alpine), formerly Nivalis Therapeutics Inc, is a pharmaceutical company. The company focuses on discovering and developing protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. It provides ALPN-101 and ALPN-303 for the treatment of based immunotherapies and immune synapses to treat cancer and autoimmune and inflammatory diseases. The company also provides ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer. It offers a proprietary scientific platform that converts native immune...
Add to Basket -
Product Insights
Deep Brain Stimulators (DBS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
DBS Pipeline Market Report Overview A Deep Brain Stimulators (DBS) is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders. One unit refers to one Deep Brain Stimulator. The DBS pipeline market research report provides comprehensive information about the DBS pipeline products with a comparative analysis of the products at...
-
Company Profile
Annexon Inc – Company Profile
Annexon Inc (Annexon) is a developer of therapeutic products and pathway inhibitors for the treatment of neurological disorders. The company develops treatments for Huntington’s disease and Alzheimer’s disease by targeting complement-mediated neurodegeneration. Its lead drug candidates include ANX005 and ANX007, which are potent inhibitory antibodies against C1q, an initiating molecule of the classical complement cascade. The company also develops ANX105, for the treatment of neurodegenerative disorders. It develops therapeutic products to protect against synapse loss and inflammatory nerve damage in...
Add to Basket -
Product Insights
Synapse Biomedical Inc, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Synapse Biomedical Inc, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are...
-
Company Profile
Razer Inc – Company Profile
Razer Inc (Razer) is involved in designing and manufacturing of gaming software and hardware peripherals. The company's products portfolio comprises gaming peripherals, including gaming mice, keyboards, audio devices, mouse mats and peripheral accessories. It also offers laptops and mobiles gaming console controllers and monitors. Razer provides lifestyle products, which include bags, gear and apparels. The company software platform comprises of cortex game booster, synapse IOT drivers, chroma RGB and gaming surround sound software. It offers Silver rewards points system and...
Add to Basket -
Product Insights
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Insulin-like growth factor 1 (IGF-1) also called somatomedin C is a protein encoded by the IGF1 gene. It stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin. It plays a role in synapse maturation. It acts as a ligand for IGF1R. The Insulin Like Growth Factor I pipeline drugs market research report provides comprehensive information on the therapeutics under development for Fibroblast Growth Factor 2, complete with analysis by stage of development,...
-
Product Insights
Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Neuronal acetylcholine receptor subunit alpha 4 plays a role in fast signal transmission at synapses. The Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) pipeline drugs market research report outlays comprehensive information on the Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. It also reviews key players involved in Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) targeted therapeutics development with respective...
-
Product Insights
Dystrophin (DMD) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Dystrophin is a cytoplasmic protein, which anchors the extracellular matrix to the cytoskeleton via F-actin. It acts as ligand for dystroglycan. It also acts as component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma. The Dystrophin - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Dystrophin, complete with...